Mometasone furoate/Salicylic acid

莫米松糠酸酯/水杨酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMometasone furoate/Salicylic acid
Drug Alias Name莫米松糠酸酯-水杨酸Mometasone-Salicylic acidMometasone/Salicylic acid莫米松糠酸酯+水杨酸Mometasone furoate+Salicylic acid +[12] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCyclooxygenases inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorCyclooxygenases
Therapy Area/IndicationsPsoriasisSkin Diseases
Global Approved IndicationsPsoriasisSkin Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/01/01
Country/TerritoryUnited States
CombinationsYes Salicylic acidMometasone furoate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPsoriasisSkin Diseases
Inactive IndicationsN/A

Other Information

ATC CodeD07AC13D07XC03R01AD09 +[4] 
Related LinksN/A